Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NeuroLinx Research Institute is a U.S.-based 501(c)(3) nonprofit neuroscience research institute focused on advancing brain science through open scientific collaboration. Founded in 2008 and based in La Jolla, California, the organization operates as a low-overhead institutional platform that funds and supports high-risk, potentially high-reward neuroscience projects rather than a traditional drug-development biotech. Its research areas span demyelination diseases and neuropathic pain, neurodegeneration biomarkers, artificial intelligence, consciousness and psychedelics, signal analysis, biomimicry, and collaborative efforts such as OpenWorm and Remote Dolphin EEG. NeuroLinx partners with academic, nonprofit, and technology groups to enable multidisciplinary research and translational neuroscience initiatives. The organization appears to be an active nonprofit research institute rather than a commercial pharma or biotech company with a conventional therapeutic pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NeuroLinx Research Institute.